Tag: Neuromodulation

Study lays foundation for treating drug, alcohol addicts with noninvasive brain...

In a study investigating the use of transcranial magnetic stimulation (TMS) for drug addiction, researchers at Medical University of South Carolina are the first...

Axonics secures US$40M financing to commercialise neuromodulation device

Axonics has secured US$40 million to support commercialisation of its neuromodulatory treatment of urinary and bowel dysfunction. The financing comes as Axonics closes in on the...

Soin Neuroscience commences a clinical case series with Nuvectra’s Algovita spinal...

Soin Neuroscience, a biotech company based in Dayton, Ohio, USA, has received IRB (institutional review board) approval to commence a clinical case series to study...

Neurostimulation can be part of the solution to the opioid crisis

The president of the United States of America has recently declared the opioid crisis in that country a “public health emergency”. In light of...

“Shuffle” stimulation improves pain scores in pilot study

A pilot study published in Neuromodulation: Technology at the Neural Interface suggests that high frequency stimulation (HFS), an alternative SCS waveform could also be...

Innovation. Outcomes. Focus on Function.

Medtronic has a long-standing commitment to delivering innovative pain stimulation technology and building the evidence that matters today and leads us into the future. This is again...

NANS responds to California DWC order to discontinue coverage of non-opioid...

The North American Neuromodulation Society (NANS) has issued a response to the California Division of Workers’ Compensation (DWC) order which adopts regulations to update the evidence-based...

Flexible battery could revolutionise implanted devices

Experts at Queen’s University Belfast, Belfast, UK, have designed a flexible battery that could provide an alternative to the rigid batteries that usually power...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

Marking 50 years of spinal cord stimulation

The year 2017 marks the 50th anniversary for spinal cord stimulation therapy which was first used to treat pain in 1967. To celebrate the...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

CE mark for Vercise Gevia deep brain stimulation system

CE mark has been granted for the Vercise Gevia deep brain stimulation (DBS) system (Boston Scientific), a rechargeable, magnetic resonance (MR) conditional device indicated...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

SureTune3 deep brain stimulation software receives Health Canada licence

Medtronic has received a Health Canada licence for SureTune3 software for deep brain stimulation (DBS). The latest innovations in the SureTune technology are designed...

CE mark approval for Stimwave’s world-first fully percutaneous spinal cord stimulator...

CE mark approval has been granted for the world’s first percutaneous injectable anchor system, SandShark. The Stimwave system is used to fixate the company’s...

Giancarlo Barolat

Over a 38-year career, Giancarlo Barolat has performed over 8000 neurostimulation procedures and has seen the field develop and change in a number of...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

How do you design unbiased neuromodulation trials?

At the annual meeting of the Neuromodulation Society of the UK and Ireland (NSUKI; 3–4 November, Manchester, USA) Alan Batterham (Health & Social Care...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

More research needed to show potential of neuromodulation

While much has been done in the past decade to advance the field of neuromodulation, some investigators believe only small steps have been made...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

New guidance on neuromodulation therapy to be published

The International Neuromodulation Society (INS) journal Neuromodulation: Technology at the Neural Interface is publishing expert, evidence-based guidance on the safe and efficient use of neuromodulation implants in patient-centred...

FDA approves BurstDR stimulation for patients with chronic pain

The US Food and Drug Administration (FDA) has approved BurstDR stimulation, a physician-designed form of spinal cord stimulation (SCS) clinically proven to provide superior outcomes for...

Study finds deep brain stimulation a cost-effective treatment method for Parkinson’s...

It has been established that deep brain stimulation is clinically superior to medical therapy for treating advanced Parkinson’s disease. Jan B Pietzsch (Department of...

Medtronic’s StealthStation cranial software receives FDA clearance as an aid for...

Medtronic has announced US Food and Drug Administration (FDA) clearance of StealthStation cranial software as an aid for deep brain stimulation (DBS) lead placement....

ReActiv8-A sustains performance at one year in clinical trial

Mainstay Medical International has announced the one-year results from the ReActiv8-A Clinical Trial, an international, multi-centre, prospective, single arm trial for ReActiv8 in people...

Study urges earlier consideration of spinal cord stimulation in chronic pain...

A study recently published in the journal Neuromodulation suggests that earlier consideration of spinal cord stimulation in chronic pain care continuum could have a...

SCS TechTalk: Innovation Starts Here

In this Boston Scientific Educational Supplement, you will read about the pace of innovation—from delivering the first and only rechargeable spinal cord stimulation (SCS) system powered by intuitive...

Most patients with chronic trunk or limb pain experience “substantial” pain...

Twenty-four month data from a postmarket, clinical registry have found that most patients suffering from chronic pain of the trunk and/or limbs reported “substantial”...

Boston Scientific acquires Cosman Medical radiofrequency ablation manufacturer

Boston Scientific Corporation has acquired Cosman Medical a privately-held manufacturer of radiofrequency ablation systems. According to a press release, the Cosman Medical team and...

Cefaly releases revamped pocket-sized model of migraine headband

Cefaly has announced that its eponymous Cefaly device—which is a US Food and Drug Administration (FDA)-approved external trigeminal nerve stimulation device for the prevention...

Higher spinal cord stimulation frequency may reduce epileptic seizure

The ability of spinal cord stimulation to affect spike-and-wave discharges has been suggested as a means to mitigate epileptic seizures in recent literature. In...

Blue Cross Blue Shield denies coverage for high-frequency spinal cord stimulation...

Blue Cross Blue Shield has denied coverage for high frequency spinal cord stimulation in at least two states. Outposts of the federation of...

St Jude Medical launches Infinity deep brain stimulation system and directional...

St Jude Medical has launched the Infinity deep brain stimulation (DBS) system and directional DBS lead in Europe. The system, which received CE mark approval...

CE mark granted to Mainstay Medical for ReActiv8

Mainstay Medical International has received CE mark approval for ReActiv8, its proprietary implantable neurostimulation system designed to treat disabling chronic low back pain. According to...

Boston Scientific receives US FDA approval for Precision Montage MRI spinal...

  Boston Scientific Corporation has launched the Precision Montage MRI spinal cord stimulator system after receiving approval from the US Food and Drug Administration (FDA)....

First US commercial implants of Axium DRG system announced

St Jude Medical has announced the US launch and first post-approval implants of the St Jude Medical Axium Neurostimulator System for dorsal root ganglion (DRG) stimulation...

Medtronic offer first complete portfolio of full-body MR conditional neurostimulation systems

The US Food and Drug Administration (FDA) has approved Medtronic’s Specify SureScan MRI surgical leads, which are indicated for use as part of Medtronic...

St. Jude Medical: Returning innovation to chronic pain treatment

With a series of acquisitions and recent product approvals, St. Jude Medical has further solidified its place as a leading provider of treatment options...

High-density stimulation restores efficacy in failed spinal cord stimulation therapy

By reprogramming existing spinal cord stimulation systems, investigators have been able to restore efficacy in patients who have failed spinal cord stimulation therapy, and...

Timothy Deer

Timothy Deer (Centre for Pain Relief, Charleston, USA) has recently been appointed president of the International Neuromodulation Society. He believes neuromodulation is now the...

Medtronic and Samsung to collaborate on telehealth solutions for neuromodulation patients

Medtronic and Samsung Electronics America are to begin a broad-based strategic alliance aiming to speed up the development of digital health solutions for those...

SUNBURST data demonstrates superior pain relief results for Burst Stimulation over...

St Jude Medical’s Burst stimulation can relieve chronic pain more effectively than traditional tonic spinal cord stimulation (SCS), according to the SUNBURST study. The...

LUMINA data demonstrate 70% greater low back pain relief with Precision...

Final results evaluating the Precision Spectra spinal cord stimulator system (Boston Scientific) demonstrate that the device provides more than 70% greater low back pain...

St Jude Medical launches spinal cord stimulation system in Europe

St Jude Medical has launched its Proclaim Elite spinal cord stimulation (SCS) system in Europe. According to a press release, this is the world’s...

FDA approves Proclaim Elite SCS System

St Jude Medical has announced FDA approval of the new Proclaim Elite Spinal Cord Stimulation System, the first and only upgradeable and recharge-free spinal cord stimulation (SCS)...

Medtronic TYRX Neuro Absorbable Antibacterial Envelope now available for use with...

Medtronic plc has announced the first implants of the TYRX Absorbable Antibacterial Envelope with Medtronic deep brain stimulation (DBS) systems. The implants were conducted...

St Jude Medical receives CE mark for MRI conditional labelling of...

St Jude Medical has received CE mark approval for magnetic resonance imaging (MRI) conditional labelling for the company’s Prodigy MRI chronic pain system with...

FDA clears St Jude Medical Invisible Trial System

St Jude Medical has received Food and Drug Administration (FDA) approval of the Invisible Trial System. The system, which received CE mark in June...

Alim Louis Benabid

Winner of the 2015 Breakthrough Prize in Life Science, the 2014 Lasker DeBakey Clinical Medical Research Award and the North American Neuromodulation Society (NANS)...

St Jude Medical completes acquisition of Spinal Modulation

Now complete, the acquisition of Spinal Modulation adds DRG stimulation technology to the St Jude Medical chronic pain portfolio.

Medtronic announces European approval of the first and only full-body MR...

The expanded approval for full-body MRI scans applies to all patients receiving a new system and to an estimated 13,000 people in Europe already receiving Medtronic DBS therapy.

St Jude Medical announces intent to acquire Spinal Modulation

Following the completion of this acquisition, St Jude Medical will become the only medical device manufacturer to offer radiofrequency ablation (RFA), spinal cord stimulation (SCS) and dorsal root ganglion (DRG) stimulation therapy solutions for the treatment of chronic pain.